Tuesday Mar 4
National Research Corp - 10-K - Management's Discussion and Analysis...
The Company is a leading provider of analytics and insights that facilitate revenue growth, patient, employee and customer retention and patient engagement for healthcare providers, payers and other healthcare organizations.
National Research Corp. Downgraded by Zacks to Underperform
They currently have a $35.70 price objective on the stock. Zacks ' target price points to a potential downside of 5.00% from the stock's previous close.
National Research Management Discusses Q4 2013 Results - Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to the -- our [ph] 2013 fourth quarter earnings release conference call.
National Research Corporation Announces Fourth Quarter and Year-End 2013 Results
In fact, the last half of 2013 registered a 36% increase in net new sales over the first half of 2013.